Kinvard Bio antibiotics are at the forefront of a revolutionary approach in the battle against drug-resistant infections.Co-founded by a team of dedicated scientists at Harvard University, this startup is pioneering a new class of antibiotics specifically designed to tackle the rising threat of bacterial resistance.